Analyst, 2020, Accepted Manuscript
DOI: 10.1039/D0AN00268B, Paper
DOI: 10.1039/D0AN00268B, Paper
Xu Wu, Liping Wang, Yan Peng, Fang Wu, Jiumei Cao, Xiaohong Chen, Wanwan Wu, Huinan Yang, Mengmeng Xing, Yiming Zhu, Yijue Shi, Songlin Zhuang
Rivaroxaban, as a direct oral anticoagulant, has been widely used in the treatment and prevention of thrombosis disease (TD). However, even if taking the same dose of rivaroxaban, different pathophysiological...
The content of this RSS Feed (c) The Royal Society of Chemistry
Rivaroxaban, as a direct oral anticoagulant, has been widely used in the treatment and prevention of thrombosis disease (TD). However, even if taking the same dose of rivaroxaban, different pathophysiological...
The content of this RSS Feed (c) The Royal Society of Chemistry
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου